P4‐291: Assessing the Impact of a Centralized Data Review on the Reliability of the Alzheimer’S Disease Assessment Scale‐Cognitive (ADAS‐COG) | Zendy

Khan Anzalee | Zendy; Atkins Alexandra S. | Zendy; Stroescu Ioan | Zendy; Davis Vicki | Zendy; Williamson Tiffany | Zendy; Mozley Lyn Harper | Zendy; Voss Tiffini | Zendy; McMahon Kerry Budd | Zendy; Keefe Richard SE. | Zendy

Premium

P4‐291: Assessing the Impact of a Centralized Data Review on the Reliability of the Alzheimer’S Disease Assessment Scale‐Cognitive (ADAS‐COG)

Author(s) -

Khan Anzalee,

Atkins Alexandra S.,

Stroescu Ioan,

Davis Vicki,

Williamson Tiffany,

Mozley Lyn Harper,

Voss Tiffini,

McMahon Kerry Budd,

Keefe Richard SE.

Publication year - 2016

Publication title -

alzheimer's and dementia

Language(s) - Czech

Resource type - Journals

SCImago Journal Rank - 6.713

H-Index - 118

eISSN - 1552-5279

pISSN - 1552-5260

DOI - 10.1016/j.jalz.2016.07.033

Subject(s) - neurocognitive , reliability (semiconductor) , cronbach's alpha , medicine , placebo , clinical trial , cognition , psychology , psychometrics , clinical psychology , psychiatry , pathology , power (physics) , physics , alternative medicine , quantum mechanics

Anzalee Khan, Alexandra S. Atkins, Ioan Stroescu, Vicki Davis, Tiffany Williamson, Lyn Harper Mozley, Tiffini Voss, Kerry Budd McMahon, Richard SE. Keefe, Neurocog Trials, Durham, NC, USA; 2 Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA; 3 NeuroCog Trials, Durham, NC, USA; Merck & Co., Inc., Kenilworth, NJ, USA; Merck & Co., Inc., Kenilworth, NJ, USA; Merck & Co., Inc., Kenilworth, NJ, USA; Duke University Medical Center, Durham, NC, USA. Contact e-mail: anzalee.khan@ neurocogtrials.com

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research